Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes

Albert Henry1,2, Xiaodong Mo3, Chris Finan1

  • 1Institute of Cardiovascular Science, University College London, London, UK.

Nature Genetics
|March 4, 2025
PubMed

Insights

This large genome-wide association study identified 66 genetic loci for heart failure (HF) and its subtypes, including 37 novel sites. Findings reveal extracardiac tissue roles and inform HF etiology, prevention, and treatment strategies.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Genomics

Background:

  • Heart failure (HF) significantly impacts global health, yet its genetic underpinnings are not fully understood.
  • Distinct HF subtypes exist, but their genetic determinants require further elucidation.

Purpose of the Study:

  • To conduct a comprehensive genome-wide association study (GWAS) for heart failure (HF) and its subtypes.
  • To identify novel genetic loci associated with HF etiology and understand their functional roles.

Main Methods:

  • Genome-wide association study (GWAS) in 1.9 million individuals, including 153,174 with HF.
  • Functional gene prioritization, phenome-wide association analysis, network analysis, and colocalization.
  • Heritability enrichment analysis and Mendelian randomization for risk factor associations.

Main Results:

  • Identified 66 genetic loci associated with HF and its subtypes, with 37 being novel.
  • Highlighted the contribution of extracardiac tissues to HF development.
  • Revealed differential associations of risk factors with HF subtypes.

Conclusions:

  • Expanded understanding of the genetic architecture of heart failure.
  • Provided insights into the mechanisms driving HF etiology.
  • Potential to inform future therapeutic and preventative strategies for HF.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
306
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
39.4K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324